UTHSC Team Awarded $2.27 Million for New Breast Cancer Therapy Research
|
A research team at the University of Tennessee Health Science Center has been awarded $2.27 million to study a potential next-generation treatment for late-stage breast cancer. Wei Li, PhD, professor of Pharmaceutical Sciences and director of the UTHSC College of Pharmacy Drug Discovery Center, and Tiffany Seagroves, PhD, professor of Pathology in the UTHSC College… Read More